Cambridge Obtains USD $3 Million Financing From Alpine Capital-Markets Inc. CALGARY, AB -- (MARKET WIRE) -- September 14, 2006 -- Cambridge Resources Inc. (PINKSHEETS: CBRP) announced today that it has entered into a financing (PIPE) agreement with Alpine Capital-Markets to fund the company's operation over the next 30 months.
According to the financing arrangement, Alpine Capital-Markets will immediately fund $250,000, which will be used acquire a permit to explore the Janvier IR 194 for oil and gas potential. Another $250,000 will be delivered on September 30, 2006 to fund an engineering report and an 8 kilometer 2D seismic program. Alpine will fund Cambridge $83,333 each month for an additional 30 months; a total committment of $3,000,000.
"We are pleased to enter into this long term funding agreement with Alpine Capital-Markets to carry out a land acquisition and property development program that we are pursuing in the prolific oil and gas area of western Canada," said Stan Ford, president and CEO of Cambridge.
About Cambridge Resources Inc.
Cambridge Resources Inc. is an oil and gas exploration and junior producer located in Vancouver and Calgary, Canada. Cambridge Resources is publicly traded company on the Over-the-Counter market under the Ticker symbol: CBRP.
Important Information About Forward-Looking Statements
All statements in this news release that are other than statements of historical facts are forward-looking statements, which contain our current expectations about our future results. Forward-looking statements involve numerous risks and uncertainties. We have attempted to identify any forward-looking statements by using words such as "anticipates," "believes," "could," "expects," "intends," "may," "should" and other similar expressions. Although we believe that the expectations reflected in all of our forward-looking statements are reasonable, we can give no assurance that such expectations will prove to be correct.
A number of factors may affect our future results and may cause those results to differ materially from those indicated in any forward-looking statements made by us or on our behalf. Such factors include our limited operating history; our need for significant capital to finance internal growth as well as strategic acquisitions; our ability to attract and retain key employees and strategic partners; our ability to achieve and maintain profitability; fluctuations in the trading price and volume of our stock; competition from other providers of similar products and services; and other unanticipated future events and conditions.
CepTor Signs Letter of Intent with Ferring Pharmaceuticals for Superoxide Dismutase; Product Targeted for Phase 2B Clinical Trials for Prevention of Chronic Respiratory Morbidity in Premature Newborns HUNT VALLEY, Md.--(BUSINESS WIRE)--Sept. 14, 2006--CepTor Corporation (OTC BB:CEPO), a biopharmaceutical company focusing on cell-targeted therapeutic products for neuromuscular and neurodegenerative diseases, announced today that it has signed a Letter of Intent (LOI) with Ferring International Center, S.A. in which Ferring plans to divest and CepTor plans to purchase recombinant human copper zinc superoxide dismutase (r-h CuZnSOD or SOD). Upon and subject to completion of due diligence culminating in an agreement with the Food and Drug Administration (FDA) on the endpoints for a phase 2B clinical trial, CepTor will pay Ferring an exclusive option payment. CepTor may exercise its option for all worldwide rights to SOD with a grant-back royalty-free license to Ferring for infertility indications. Ferring will retain contract manufacturing rights.
Aaron Graff, Senior Vice President, Global Marketing, Medical Services and Business Development at Ferring, said, "With CepTor, we feel we have put this product in the best hands to get it approved. Ultimately, product approval was the most important consideration in our divestiture decision. This agreement came about as a result of understanding the historical relationship of CepTor's staff with the development of SOD, their knowledge and ability to move it forward and the neonatology community's overwhelming support of them."
Bill Pursley, Chairman and CEO of CepTor, remarked, "Considering our staff's experience in this area, SOD represents a perfect fit for the Company. SOD is an advanced stage product with orphan status in the U.S. and EU, representing a $400 million market opportunity for an unmet medical need. Ferring has been extremely supportive and its efficiency and expediency throughout this process is representative of the company's entrepreneurial spirit."
CepTor's Executive Vice President and Chief Medical Officer, Norman Barton, M.D., Ph.D., said, "We have this opportunity because our staff is familiar with and believes in this product. SOD has successfully completed phase 1 and 1B safety studies and a 302-patient phase 2 study. The latter revealed a significant reduction in all cause pulmonary morbidity at one year corrected age with the results published in Pediatrics. We are excited about the prospect of entering a phase 2B study to duplicate these clinically relevant outcomes."
Debra Birenbaum, M.D., trained in neonatology and former Medical Officer in the Pulmonary Division at the FDA's Center for Drug Evaluation and Research, stated, "There has been a significant paradigm shift in the way that the scientific, neonatology and regulatory communities evaluate the endpoints in this population. As published in last March's Pediatrics, we now know and accept that improvement in chronic respiratory, neurodevelopmental and neurological morbidity in these neonates are clinically meaningful goals and, therefore, appropriate endpoints for study. Bronchopulmonary dysplasia (BPD) as defined in the 1980's and 90's is not a meaningful or clinically relevant isolated endpoint."
Jonathan Davis, M.D., Chief of Newborn Medicine at Tufts-New England Medical Center, said, "The neonatology community understands the importance of SOD's development. We are excited about the long-term benefit we believe it can bring these children. We look forward to working with CepTor in this endeavor and in planning and conducting clinical trials at our institution."
About CepTor Corporation
CepTor Corporation is a development-stage biopharmaceutical company engaged in the discovery, development, and commercialization of proprietary, cell-targeted therapeutic products for the treatment of neuromuscular and neurodegenerative diseases with a focus on orphan diseases. CepTor's primary efforts are currently focused on moving its lead product, Myodur, into clinical trials for Duchenne muscular dystrophy. The Company's broad platform technology also includes the development of products for multiple sclerosis (MS), chronic inflammatory demyelinating polyneuropathy (CIDP) and amyotrophic lateral sclerosis (ALS). More information about CepTor can be found at www.ceptorcorp.com.
About Ferring International Center, S.A
Ferring is a Swiss-based research driven, specialty biopharmaceutical group active in global markets. The company identifies, develops and markets innovative products in the areas of endocrinology, gastroenterology, gynecology, infertility and urology. In recent years Ferring has expanded beyond its traditional European base and now has offices in over 40 countries. To learn more about Ferring or its products please visit www.ferring.com.
The press release contains forward-looking statements. These statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. These statements are based on our current beliefs and expectations as to such future outcomes. Drug discovery and development involves a high degree of risk. Factors that might cause such a material difference include, among others, uncertainties related to the ability to attract and retain partners for our technologies, the identification of lead compounds, the successful preclinical development thereof, the completion of clinical trials, the FDA review process and other government regulation on our ability to successfully develop and commercialize drug candidates, competition from other pharmaceutical companies, product pricing and third party reimbursement. The Company disclaims any obligation to update any forward-looking statement as a result of developments occurring after the date of this press release.
Contacts CepTor Corporation Donald W. Fallon, 410-527-9998 Fax: 410-527-9867 dfallon*ceptorcorp.com or Wolfe Axelrod Weinberger Assoc. LLC Donald C. Weinberger Alisa D. Steinberg (Media) 212-370-4500 Fax: 212-370-4505 don*wolfeaxelrod.com alisa*wolfeaxelrod.com
-------------------- Hi-ho Momo, awayyyy... Posts: 871 | From: So. Cal | Registered: May 2006
| IP: Logged |
Ewan 1 to Appear on MN 1.com SANTA ANA, CA -- (MARKET WIRE) -- September 14, 2006 -- Todd Chassion and Craig Erickson of Ewan 1 (PINKSHEETS: EWAN) will be featured live on Market News First (www.MN 1.com) for an exclusive interview with the MN 1 news team. The interview is scheduled for Sept. 21, 2006, at 1:00PM CDT.
Ewan 1 (PINKSHEETS: EWAN) is a developer of technology and equipment that enables broadcasters the most secure method of encryption for the rebroadcast of mainstream content over the internet. Video and television content can be rebroadcast in real-time or on demand to consumers over internet protocol in near High-Definition (HD) quality. Thanks to the revolutionary patented security solution developed by the team at Ewan 1, broadcasters can ensure content providers that their transmission over the internet will be as secure as possible. Using bank-level security, Ewan 1 gives broadcasters their own feeling of true protection. This proprietary solution is patented and bears the name AccessKey™, which includes a set-top box product and a portable USB device product. Not only is the security itself unique, but this enables consumers to turn any computer into a television, enabling users to receive their favorite TV programming anywhere on earth by plugging the USB device and product into their laptop or home computer. The plan at Ewan 1 is to sell or license their AccessKey™ security technology to broadcasters worldwide enabling them to acquire mainstream content for rebroadcast over the internet.
Join Todd Chassion and Craig Erickson to learn more about the goals of the company, as well as its position in the stock market.
About MN 1.com
Market News First is an online, market news provider that brings investors current news regarding investments, entertainment, and sports. Market News First is the only live online video webcast that brings real news to its audience while featuring live interaction with companies from the Bulletin Board to the NYSE.
Through daily, live interviews, we bring you up to date on all the established companies and inform the investors of the newest opportunities within the market. Market News First offers one-on-one interviews with the CEOs and CFOs of companies to deliver answers to the questions that investors are concerned with most. This provides viewers the ever-important insight into the companies' present condition and future plans. Tune into MN 1.com for our live video webcast each weekday from 8:30am to 8:00pm Eastern time.
posted
SGDS (.14) - COHQ (.005) September 14, 2006 04:56 PM ET
Stronghold Issues Shareholder Communication SANTA MONICA, Calif.--(BUSINESS WIRE)--Sept. 14, 2006--Stronghold Industries, Inc. (OTC:SGDS), a CorpHQ, Inc. (OTC:COHQ) portfolio company, today issued a Shareholder Communication regarding the process to exchange current stock certificates into Stronghold Industries, Inc. stock certificates.
Stronghold Industries, Inc., through its wholly-owned subsidiary, Moore Protection, is one of the premier high-end home security providers in Southern California with a high-demographic client base spanning the entertainment, legal and business communities. Stronghold's strategy is to grow both organically and through strategic acquisitions of companies that span the landscape of residential security, entertainment and technology. The company's website is: www.sgtvinc.com.
Forward-Looking Statements
Any statements made in this press release that are not based on historical facts are "forward-looking statements", as such term is defined in the Private Litigation Reform Act of 1995. Although such statements are based on management's current estimates and expectations, and currently available competitive, financial, and economic data; forward-looking statements are inherently uncertain. We, therefore, caution the reader that there are a variety of factors that could cause business conditions and results to differ materially from what is contained in our forward-looking statements. For a description of some of the factors which may occur that could cause actual results to differ from our forward-looking statements please refer to our 2005 Voluntary Annual Report, and in particular the discussions contained under "Risk Factors."
Contacts CorpHQ, Inc. Investor Relations Gregg Davis, 310-683-0404 gregg*corphq.com
At A Glance CorpHQ Inc. Source: via Business Wire Updated 06/12/2006 by company Headquarters: Redondo Beach, CA Website: http://www.corphq.com CEO: Steve Crane Employees: 12 Ticker: COHQ (PinkSheets) Revenues: $2,572,514 (2005) Net Income: $649,303 (2005)
-------------------- Hi-ho Momo, awayyyy... Posts: 871 | From: So. Cal | Registered: May 2006
| IP: Logged |
Innova Holdings, Inc. Notifies Stockholders That the Special Meeting of Stockholders Tentatively Scheduled for Friday, September 15 Is Postponed
Market Wire "US Press Releases "
FORT MYERS, FL -- (MARKET WIRE) -- 09/14/06 -- Innova Holdings, Inc. (OTCBB: IVHG), a robotics technology firm providing software and hardware systems to the service, personal, and industrial robot markets, today announced that the Special Meeting of Stockholders tentatively scheduled for Friday, September 15, 2006 has been postponed.
One of the proposals to be put to a vote of the stockholders is a reverse stock split of the issued and outstanding shares of common stock at a ratio of either one-for-eight or one-for-ten, as determined at the discretion of the board of directors to be in the best interests of the Company without further approval from our stockholders.
The company is awaiting SEC approval on this issue, after which the meeting date will be finalized.
When the meeting is held it will be held at Sanibar Harbour Resort located at 17260 Harbour Pointe Drive, Fort Myers, FL 33908, www.sanibel- resort.com, which is a short distance from the company's headquarters.
The company plans to have on display at its headquarters a number of products including the new Universal Robot Controller 3(TM) (URC3(TM)) which was recently launched by the Robotic Workspace Technologies, Inc. (RWT(TM)) subsidiary as a result of technology innovations developed for the previously announced NASA contract, and also Mesa Robotics Inc. unmanned ground vehicles, for which the Innova Robotics subsidiary has exclusive worldwide sales and marketing rights. Representatives from the CoroWare subsidiary will also attend to demonstrate their software tools.
About Innova Holdings, Inc.
Fort Myers, FL-based Innova Holdings, Inc. (OTCBB: IVHG), through its subsidiaries, provides hardware and software systems-based solutions to the military, service, personal and industrial robots markets. The robotics and automation technology company is chartered to continue expanding its growing suite of technologies through acquisitions and growth. Its founder, Chairman and CEO Walter K. Weisel, is recognized as a pioneer and leader in the robotics industry. The company's wholly owned subsidiaries are Robotic Workspace Technologies Inc. (RWT), Innova Robotics Inc., and CoroWare. To learn more, visit us online at www.InnovaHoldings.com.
Investor Relations
Investors can visit Innova Holdings' Investor Relations Hub at www.agoracom.com/IR/Innova to post questions and receive answers, or simply review questions and answers by other investors. They may also request to be added to the investor e-mail list.
The names of actual companies and products mentioned herein may be the trademarks of their respective owners.
Forward-looking statements such as "believe," "expect," "may," "plan," "intend," etc., contained herein are within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve risks and uncertainties and are based on the company's beliefs and assumptions it made using information currently available to it and which reflect current views concerning those future events. Actual results could differ materially. Therefore, undue reliance should not be placed on any forward-looking statements, since they apply only as of today's date, and accordingly, reference should be made to the company's periodic filings with the SEC.
FOR MORE INFORMATION: Sandra L. Brooks INCOMM International Inc. 7825 Baymeadows Way, Suite 101-A Jacksonville, FL 32256 Tel: (904) 636-5085 Email: slbrooks*incomminternational.com URL: www.incomminternational.com
Universal Detection Technology's BSM-2000, Anthrax Detection Unit, Featured on U.S. Department of Commerce's Web Site in Canada via COMTEX
September 15, 2006
LOS ANGELES, Sept. 15, 2006, Sep 15, 2006 (PRIMEZONE via COMTEX News Network) --
Universal Detection Technology (OTCBB:UDTT); (FWB:PO8), a developer of early-warning monitoring technologies to protect people from bioterrorism and other infectious health threats, announced today that it is included in the Commercial Service's list of Featured U.S. Exporters (FUSE) in Canada.
The U.S. Commercial Service through its offices at the American Embassy in Canada is pleased to promote UDTT's products. UDTT's information has been posted on the local U.S. Commercial Service website and can be viewed at: http://www.buyusa.gov/canada/en/fuse.html?exp_cat=6010&exp_pid=443.
FUSE is a directory of U.S. products featured on U.S. Commercial Service websites around the world. It gives U.S. companies an opportunity to target specific markets in the local language of business. Currently, listings are offered to qualified U.S. exporters seeking trade leads or representation in over 50 markets around the world. This service is offered for a fee.
Buyers and importers interested in UDTT's products will contact the U.S. Commercial Service's office for more information and the Company will also receive the prospects' contact information.
About U.S. Commercial Service
The U.S. Commercial Service is a part of the U.S. Department of Commerce and is active in promoting the sales and presence of U.S. companies in various markets around the world. With offices in the U.S. and in several foreign territories the U.S. Commercial Service offers several ways to grow U.S. businesses' international sales. The tasks of the Commercial Service include, and are not limited to, world-class market research, trade events that promote U.S. products or services to qualified buyers, introductions to qualified buyers and distributors, and counseling through every step of the export process.
About Universal Detection Technology
Universal Detection Technology is a developer of monitoring technologies, including bio-terrorism detection devices. The Company on its own and with development partners is positioned it to capitalize on opportunities related to Homeland Security. For example, the Company, in cooperation with NASA has developed a bio-terror 'smoke' detector that detects certain bio hazard substances. For more information, please visit http://www.udetection.com.
Universal Detection Technology Jacques Tizabi (310) 248-3655 jtizabi*udetection.com CEOcast, Inc. for Universal Detection Technology Andrew Hellman (212) 732-4300
(C) 2006 PRIMEZONE, All rights reserved.
-------------------- A million seconds is 13 days. A billion seconds is 31 years. Posts: 4893 | From: Burbank IL USA | Registered: Feb 2004
| IP: Logged |
posted
Company Reminds Shareholders That Shares Purchased as a Result of Exercising Current Warrants Are Exempt from Reverse Splits for 12 Months Following the Purchase
ORLANDO, Fla.--(BUSINESS WIRE)--Sept. 15, 2006--Raven Moon Entertainment, Inc. (OTCBB:RVEM - News) announced today that founders Joey and Bernadette DiFrancesco have exercised the company's current 10-for-1 warrants to buy 5 billion shares of restricted common stock that will be exempt from the announced 1-for-200 reverse split on September 20, 2006, as well as from any reverse splits for 12 months following the purchase of the shares. ADVERTISEMENT
"With only about five days left before the approved 1-for-200 reverse split takes place on September 20, 2006, the company is reminding shareholders that they can protect their positions by exercising their warrants. Shareholders who exercise their 10-for-1 warrants are helping the company and themselves because the company's Board of Directors has authorized the exemption of restricted shares purchased as a result of exercising the current warrant from any potential reverse split that may occur for 12 months," stated Joey DiFrancesco, Chairman and CEO of Raven Moon Entertainment.
10-for-1 Warrant Terms and Exercise Instructions
The terms of the warrant dividend are: shareholders of record as of September 1, 2006 shall receive 1 warrant for each share of common stock owned as of that date. The warrant allows the shareholder to exercise 10 shares of common restricted stock for each warrant they own and exercise during a one-month window beginning September 15, 2006 to October 15, 2006 at a 50% discount of the closing ask price on the day their check is dated. Common shares purchased as a result of exercising warrants will be restricted for one year. All transactions when accepted by the company are final and irrevocable. The company will not accept an exercise that totals less than $25.00.
If your account is with a broker, send a copy of your account statement to Raven Moon Entertainment, 2005 Tree Fork Lane, Suite 101, Longwood, FL 32750 no later than October 15, 2006 verifying the number of shares you owned in your account as of September 1, 2006. Indicate the number of warrants you would like to exercise at a 50% discount of the closing ask on the day you write your check and make it payable to Raven Moon Entertainment, Inc. Please provide instructions on where the restricted common shares should be sent.
Shareholders or brokers who need further information on how to exercise these warrants may contact Carol Merry at Fahlgren Mortine Investor Relations at (614) 825-1750 or by email: carol.merry*fahlgren.com.
Safe Harbor Act Notice: This release may contain forward-looking statements that involve risks and uncertainties, including without limitation, acceptance of the company's products, increased levels of competition, product and technological changes, the company's dependence upon financing and third-party suppliers, and other risks detailed from time to time in the company's federal filings, annual report, offering memorandum or prospectus. Specifications are subject to change without notice.
Contact: For Raven Moon Entertainment, Inc., Orlando Fahlgren Mortine Investor Relations Carol Merry, 614-825-1750 carol.merry*fahlgren.com
-------------------------------------------------------------------------------- Source: Raven Moon Entertainment, Inc.
-------------------- Get rich or at least richer Posts: 9 | Registered: Aug 2006
| IP: Logged |
NEW YORK, Sep 15, 2006 (BUSINESS WIRE) -- Laidlaw Energy Group, Inc. (OTC:LLEG) announced today that it is reviewing several new renewable energy project development opportunities in anticipation of adding one or more projects to its development pipeline. One such opportunity involves utilizing a Rolls Royce/Allison turbine and two other gas fired engines currently owned by an affiliate of LLEG in connection with a landfill gas project. Landfill gas generation projects use the gas generated from the decomposition of organic materials at landfill disposal sites as a renewable fuel source for a gas turbine/generator.
Aside from opportunities originated by LLEG and its partners, LLEG has also received a significant number of inquiries from other parties, including municipal entities, other power developers and large manufacturing businesses, about potential new generation projects. LLEG has also submitted offers on two other generation facilities that are currently for sale.
"We want the market to be aware that we have an appetite to make more acquisitions in this sector and intend to move aggressively to accumulate assets that meet our criteria," stated Laidlaw Energy CEO Michael B. Bartoszek. "Although we have an aggressive hurdle rate for our equity returns, we are very non-commercial about our approach to transactions and have the ability to move very quickly."
About Laidlaw Energy Group
Laidlaw Energy Group (LLEG) is engaged in the development of independent power plants that generate electricity from renewable resources. LLEG's mission is to build and manage a profitable portfolio of renewable energy facilities through development, acquisition, conversion of existing facilities and through partnering with manufactures that have significant electric and thermal needs. LLEG is headquartered in New York, New York. For more information on LLEG, please visit our website at NYENRG.com.
This communication contains statements expressing expectations of future events and/or results which may include, without limitation, statements concerning anticipated financial performance, business prospects, technological developments, potential markets, new products, research and development activities and similar matters. Such statements constitute forward-looking statements made pursuant to the Safe Harbor provision of the Private Securities Litigation Reform Act of 1995. All statements based on future expectations rather than historical facts are forward-looking statements that involve a number of risks and uncertainties, and LLEG cannot provide assurance that such statements will prove to be correct. LLEG undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
SOURCE: Laidlaw Energy Group, Inc.
Laidlaw Energy Group, Inc. Michael B. Bartoszek, 212-480-9884 info*LaidlawEnergy.com
Copyright Business Wire 2006
Posts: 572 | From: usa | Registered: Aug 2006
| IP: Logged |
Sub-Surface Waste Management of Delaware, Inc. (OTCBB:SSWM), announced that its Mexico subsidiary company Environmental Tec International, S.A. de C.V. (ETI) received a letter of authorization from the State of Puebla's Governor, Mario Marin Torres, authorizing Puebla's Secretary of the Environment, Francisco Montemayor, to contract with ETI to address two separate sites, critically impacted from petroleum product releases, that have closed established freshwater stream fed commercial aquatic fish farm sites in the northern area of the State.
Bruce Beattie, CEO of SSWM, stated, "The Los Pinos, Puebla project contract is valued at $902,000 USD and the San Lorenzo, Puebla project contract is valued at $1,078,000 USD. ETI staff will commence work at these sites immediately."
About Sub-Surface Waste Management
Sub-Surface Waste Management Inc., a majority owned subsidiary of U.S. Microbics, Inc., (OTCBB:BUGS), provides comprehensive civil and environmental engineering project management services including specialists to design, permit, build and operate environmental waste clean-up treatment systems using conventional, biological and filtration technologies. SSWM is capitalizing on its patented technologies registered in Mexico with SEMARNAT, a Federal regulatory agency overseeing environmental compliance nationwide.
Investors and media contact Bruce Beattie at 760/918-1860, ext. 105 or bbeattie*bugsatwork.com; or learn about the company by visiting its Web site at www.subsurfacewastemanagement.com.
The information contained in this press release includes forward-looking statements. Forward-looking statements usually contain the words "estimate," "anticipate," "believe," "expect" or similar expressions that involve risks and uncertainties. These risks and uncertainties include the company's status as a startup company with uncertain profitability, need for significant capital, uncertainty concerning market acceptance of its products, competition, limited service and manufacturing facilities, dependence on technological developments and protection of its intellectual property. The company's actual results could differ materially from those discussed herein. Factors that could cause or contribute to such differences are discussed more fully in the "Risk Factors," "Management's Discussion and Analysis or Plan of Operation" and other sections of the company's Form 10-KSB and other publicly available information regarding the company on file with the Securities and Exchange Commission. The company will provide you with copies of this information upon request.
Source: Sub-Surface Waste Management Inc.
-------------------- The difference between genius and stupidity is that genius has its limits Posts: 10204 | From: NYC | Registered: Mar 2006
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
